UNSPSC 51161568: Eprozinol hydrochloride

This classification denotes a histamine-1 receptor antagonist with the molecular formula C22H30N2O2.2CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X9AMI360PI. European Medicines Agency schedules eprozinol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01921MIG. The term eprozinol hydrochloride is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule eprozinol hydrochloride under HS 29335995 and SITC 51576.

As of Q4 2014, EPROZINOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: COC(CN1CCN(CC1)CCC(C2CCCCC2)O)C3CCCCC3.CL.CL.

UNSPSC 51161568 Eprozinol hydrochloride, a Commodity code, represents a narrow pharmaceutical active ingredient with virtually no recent state and local procurement activity. State and local government does not routinely purchase raw pharmaceutical compounds; the code appears to reflect federal or clinical inventory taxonomy rather than typical state and local procurement workflows. No recent state and local contract opportunities are recorded under this code.

This code is not a practical business development target in state and local markets at present.